Prognostic factors in cancer of unknown primary site

被引:15
|
作者
Jose Fernandez-Cotarelo, Maria [1 ]
Manuel Guerra-Vales, Juan [2 ]
Colina, Francisco [3 ]
de la Cruz, Javier [4 ]
机构
[1] Hosp Mostoles, Dept Internal Med, Madrid 28935, Spain
[2] Univ Hosp 12 Octubre, CIBERESP, Dept Internal Med, Madrid, Spain
[3] Univ Hosp 12 Octubre, CIBERESP, Dept Pathol, Madrid, Spain
[4] Univ Hosp 12 Octubre, CIBERESP, Clin Epidemiol Unit, Madrid, Spain
来源
TUMORI JOURNAL | 2010年 / 96卷 / 01期
关键词
tumor metastasis; unknown primary tumors; survival; prognosis; SERUM-ALBUMIN LEVELS; PRIMARY-CARCINOMA; LIVER METASTASIS; PRIMARY ORIGIN; PRIMARY TUMORS; SURVIVAL; MANAGEMENT; MARKERS; MODEL; EXPERIENCE;
D O I
10.1177/030089161009600118
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aims and background. Patients with cancer of an unknown primary site (CUP) usually have a poor outcome. The identification of prognostic factors that affect survival can help clinicians find a better approach to such cases in terms of diagnostic and therapeutic management. Methods. We conducted a retrospective study including the cases of CUP recorded at the University Hospital 12 de Octubre Tumor Registry between 1999 and 2003. Results. CUP was diagnosed in 265 patients during the analyzed period. One hundred and seventy-one were men (64.5%) and the mean age of the patients was 66.9 years (range 32-98 years). The median survival was 2.5 months, and the survival rate was 35.1% 6 months from diagnosis (95% CI: 28.9-41.3) and 24.5% 1 year from diagnosis (95% CI:.18.7-30.3). Univariate analysis revealed as significant predictive variables of a better outcome age under 70 years; involvement of a single organ; normal serum levels of alkaline phosphatase and albumin; normal erythrocyte sedimentation rate; normal levels of the serum tumor markers CEA, CA 19.9 and CA 15.3; squamous carcinoma histology; clinical presentation as lymph node enlargement; and the administration of treatment. Multivariate analysis showed that albumin and alkaline phosphatase levels, squamous carcinoma histology, age and treatment were the most important prognostic factors. Other variables analyzed (liver, bone or lung involvement, lactate dehydrogenase levels, gender) did not affect survival. Conclusions. CUP has a poor prognosis. Some prognostic factors that affect survival in these patients, however, may be identified. Free full text available at www.turnorionline.it
引用
收藏
页码:111 / 116
页数:6
相关论文
共 50 条
  • [21] Cancer of unknown primary site
    Gallagher, Chris J.
    Reznek, Rodney H.
    CLINICAL MEDICINE, 2008, 8 (04) : 451 - 454
  • [22] Cancer of unknown primary site
    Vajdic, Claire M.
    Goldstein, David
    AUSTRALIAN FAMILY PHYSICIAN, 2015, 44 (09) : 640 - 643
  • [23] Cancer of Unknown Primary Site
    Varadhachary, Gauri R.
    Raber, Martin N.
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (08): : 757 - 765
  • [24] Assessment of Prognostic Factors, Clinical Features Including the Microbiome, and Treatment Outcomes in Patients with Cancer of Unknown Primary Site
    Dorobisz, Karolina
    Dorobisz, Tadeusz
    Pazdro-Zastawny, Katarzyna
    CANCERS, 2024, 16 (19)
  • [25] The prognostic impact of the putative primary site of breast and ovarian cancers in an unfavorable subset of cancer of unknown primary site
    Kodaira, M.
    Yonemori, K.
    Shimoi, T.
    Shimomura, A.
    Yunokawa, M.
    Shimizu, C.
    Fujiwara, Y.
    Tamura, K.
    ANNALS OF ONCOLOGY, 2016, 27
  • [26] METASTATIC CANCER OF UNKNOWN PRIMARY SITE
    HOBBS, J
    RODRIGUEZ, AR
    AMERICAN FAMILY PHYSICIAN, 1980, 22 (03) : 164 - 168
  • [27] Cancer from an unknown primary site
    Dowell, JE
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2003, 326 (01): : 35 - 46
  • [28] METASTATIC CANCER OF UNKNOWN PRIMARY SITE
    HOLMES, FF
    FOUTS, TL
    CANCER, 1970, 26 (04) : 816 - &
  • [29] CUP -: Cancer of unknown primary site
    König, M
    Shadouh, S
    Boeminghaus, F
    AKTUELLE UROLOGIE, 2000, 31 (06) : 341 - 346
  • [30] PROGNOSTIC FACTORS IN METASTATIC CARCINOMA OF UNKNOWN PRIMARY
    PASTERZ, R
    SAVARAJ, N
    BURGESS, M
    JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (11) : 1652 - 1657